CBD is a popular activator of TRPV2 receptors, but THC is regarded as probably the most powerful cannabinoid on this target. The clinical importance of THC’s conversation with TRPV2 continues to be a focus of investigation.Verywell Brain's material is for informational and academic uses only. Our website isn't meant to be considered a substitute